Fractyl Laboratories Inc

fractyl-web-logoFractyl Laboratories Inc. has developed an endoscopic procedure for the treatment of insulin resistance and Type 2 Diabetes called Revita™ Duodenal Mucosal Resurfacing (DMR). This investigational procedure is designed to address the intestinal cause of insulin resistance and restore metabolic health in patients suffering from type 2 diabetes and nonalcoholic steatohepatitis (NASH). Visit www.fractyl.com